- Home
- IGC vs AUST Comparison
IGC vs AUST Comparison
Compare IGC & AUST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- AUST
- Stock Information
- Founded
- IGC 2005
- AUST 2020
- Country
- IGC United States
- AUST Canada
- Employees
- IGC N/A
- AUST N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- AUST
- Sector
- IGC Health Care
- AUST
- Exchange
- IGC Nasdaq
- AUST Nasdaq
- Market Cap
- IGC 20.2M
- AUST 16.9M
- IPO Year
- IGC N/A
- AUST 2022
- Fundamental
- Price
- IGC $0.31
- AUST $1.42
- Analyst Decision
- IGC Strong Buy
- AUST
- Analyst Count
- IGC 2
- AUST 0
- Target Price
- IGC $3.88
- AUST N/A
- AVG Volume (30 Days)
- IGC 230.9K
- AUST 81.4K
- Earning Date
- IGC 08-07-2025
- AUST 08-06-2025
- Dividend Yield
- IGC N/A
- AUST N/A
- EPS Growth
- IGC N/A
- AUST N/A
- EPS
- IGC N/A
- AUST N/A
- Revenue
- IGC $1,236,000.00
- AUST N/A
- Revenue This Year
- IGC N/A
- AUST N/A
- Revenue Next Year
- IGC $16.45
- AUST N/A
- P/E Ratio
- IGC N/A
- AUST N/A
- Revenue Growth
- IGC 1.65
- AUST N/A
- 52 Week Low
- IGC $0.25
- AUST $0.79
- 52 Week High
- IGC $0.55
- AUST $3.19
- Technical
- Relative Strength Index (RSI)
- IGC 49.31
- AUST 47.88
- Support Level
- IGC $0.30
- AUST $1.50
- Resistance Level
- IGC $0.32
- AUST $1.59
- Average True Range (ATR)
- IGC 0.02
- AUST 0.12
- MACD
- IGC -0.00
- AUST -0.01
- Stochastic Oscillator
- IGC 20.00
- AUST 32.43
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.
About AUST Austin Gold Corp.
Austin Gold Corp is focused on the acquisition, exploration and evaluation of mineral resource properties in the western United States of America (USA). Exploration and development of mineral projects is considered the Company's single business segment. Its projects include Kelly Creek in Humboldt County, Lone Mountain and Miller in Elko County, and Stockade Mountain (Oregon).